Prenatal exposure to drugs: effects on brain development and implications for policy and education. Thompson BL, Levitt P, Stanwood GD (2009) Nat Rev Neurosci 10: 303-12 Period determination in the food-entrainable and methamphetamine-sensitive circadian oscillator(s). Pendergast JS, Oda GA, Niswender KD, Yamazaki S (2012) Proc Natl Acad Sci U S A 109: 14218-23 Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia. Matsumoto RR, Seminerio MJ, Turner RC, Robson MJ, Nguyen L, Miller DB, O'Callaghan JP (2014) Pharmacol Ther 144: 28-40 Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. Baucum AJ, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE (2004) J Neurosci 24: 3436-43 SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, Matsumoto RR (2014) Exp Neurol 254: 180-9 SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Robson MJ, Turner RC, Naser ZJ, McCurdy CR, Huber JD, Matsumoto RR (2013) Exp Neurol 247: 134-42 Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. Kaushal N, Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR (2013) Eur Neuropsychopharmacol 23: 960-71 AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells. Kaushal N, Elliott M, Robson MJ, Iyer AK, Rojanasakul Y, Coop A, Matsumoto RR (2012) Mol Pharmacol 81: 299-308 Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine. Seminerio MJ, Robson MJ, Abdelazeem AH, Mesangeau C, Jamalapuram S, Avery BA, McCurdy CR, Matsumoto RR (2012) AAPS J 14: 43-51 Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. Hadlock GC, Baucum AJ, King JL, Horner KA, Cook GA, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE (2009) J Pharmacol Exp Ther 329: 169-74 Methamphetamine administration reduces hippocampal vesicular monoamine transporter-2 uptake. Rau KS, Birdsall E, Volz TJ, Riordan JA, Baucum AJ, Adair BP, Bitter R, Gibb JW, Hanson GR, Fleckenstein AE (2006) J Pharmacol Exp Ther 318: 676-82 The complex relationship between the light-entrainable and methamphetamine-sensitive circadian oscillators: evidence from behavioral studies of Period-mutant mice. Pendergast JS, Niswender KD, Yamazaki S (2013) Eur J Neurosci 38: 3044-53 Acceleration of HIV dementia with methamphetamine and cocaine. Nath A, Maragos WF, Avison MJ, Schmitt FA, Berger JR (2001) J Neurovirol 7: 66-71 Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus. Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR (2012) Eur J Pharmacol 691: 103-9 Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro. Kaushal N, Robson MJ, Rosen A, McCurdy CR, Matsumoto RR (2014) Eur J Pharmacol 724: 193-203 Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit. North A, Swant J, Salvatore MF, Gamble-George J, Prins P, Butler B, Mittal MK, Heltsley R, Clark JT, Khoshbouei H (2013) Synapse 67: 245-57 σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Robson MJ, Seminerio MJ, McCurdy CR, Coop A, Matsumoto RR (2013) Pharmacol Rep 65: 343-9
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.